PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class II Medicine Recall of Doximar (Doxycycline 100mg) Capsules Batch Number BPL 281A

The Pharmacy and Poisons Board has mandated Biopharma Ltd to recall Doximar (Doxycycline 100mg) Capsules

From: Pharmacy and Poisons Board

Published: 1st August 2024

Recall Reference Number: REC/2024/018

Recall Classification: Class II

Recall Level: Retail/Facility level

Manufacturer: Biopharma Ltd, Kenya

Product name: Doximar Capsules

Active Pharmaceutical Ingredient: Doxycycline 100mg

Affected Counties: All

Affected Batches

Batch Number

Date of Manufacture

Date of expiry

Pack Size

BPL 149A

08/23

07/26

100’s

Brief description of the problem

The Pharmacy and Poisons Board (PPB) collected samples of Doximar (Doxycycline 100) Batch No. BPL281A, manufactured by Biopharma Ltd, during routine market surveillance activities, for purposes of quality control testing to check compliance with the registered specifications. The test results found that the product fails to comply with specifications on the test parameters for assay, dissolution, and weight variation.

Action for healthcare professionals

Quarantine all remaining stock and stop further distribution, sale, issuing or use of the above batches immediately. Await contact from Biopharma Ltd to arrange return.

Action for patients and caregivers

No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall. You are advised to talk to your healthcare professional if you have the above batch of Doximar capsules.

 Further Information

For inquiries on consignments of the impacted batches please contact Biopharma Ltd at: info@biopharmaltd.com Tel: +254 717768794

Promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further enquiries and feedback on the product recall, kindly contact the post-marketing surveillance unit of The Pharmacy and Poisons Board Kenya via email at pms@ppb.go.ke

Download document

Medicine Quality Alert: Class II Medicine Recall of Doximar (Doxycycline 100mg) Capsules Batch number BPL 281A